Skip to main content
. 2019 Jan 24;53(1):1801908. doi: 10.1183/13993003.01908-2018

FIGURE 1.

FIGURE 1

Duration of main registration studies (randomised controlled trials (RCTs)) for currently approved pulmonary arterial hypertension therapies. Blue bars: RCTs with change in 6-min walk distance as primary outcome measure; red bars: RCTs with morbidity and mortality composite primary outcome measure.